AZD6738 for Patients With Progressive MDS or CMML

NCT03770429 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndrome

Interventions

DRUG: AZD6738

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]